Literature DB >> 24149185

Controlled substances and innovation of biomedicine: a preclinical perspective.

Adam Michael Stewart1, Allan V Kalueff.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 24149185     DOI: 10.1038/nrn3530-c1

Source DB:  PubMed          Journal:  Nat Rev Neurosci        ISSN: 1471-003X            Impact factor:   34.870


× No keyword cloud information.
  9 in total

1.  Effects of NMDA receptor antagonists: implications for the pathophysiology of schizophrenia.

Authors:  John H Krystal; Amit Anand; Bita Moghaddam
Journal:  Arch Gen Psychiatry       Date:  2002-07

Review 2.  Animal models of neuropsychiatric disorders.

Authors:  Eric J Nestler; Steven E Hyman
Journal:  Nat Neurosci       Date:  2010-09-27       Impact factor: 24.884

3.  Grand challenges in global mental health.

Authors:  Pamela Y Collins; Vikram Patel; Sarah S Joestl; Dana March; Thomas R Insel; Abdallah S Daar; Warwick Anderson; Muhammad A Dhansay; Anthony Phillips; Susan Shurin; Mark Walport; Wendy Ewart; Sir John Savill; Isabel A Bordin; E Jane Costello; Maureen Durkin; Christopher Fairburn; Roger I Glass; Wayne Hall; Yueqin Huang; Steven E Hyman; Kay Jamison; Sylvia Kaaya; Shitij Kapur; Arthur Kleinman; Adesola Ogunniyi; Angel Otero-Ojeda; Mu-Ming Poo; Vijayalakshmi Ravindranath; Barbara J Sahakian; Shekhar Saxena; Peter A Singer; Dan J Stein
Journal:  Nature       Date:  2011-07-06       Impact factor: 49.962

4.  Unique and potent effects of acute ibogaine on zebrafish: the developing utility of novel aquatic models for hallucinogenic drug research.

Authors:  Jonathan Cachat; Evan J Kyzar; Christopher Collins; Siddharth Gaikwad; Jeremy Green; Andrew Roth; Mohamed El-Ounsi; Ari Davis; Mimi Pham; Samuel Landsman; Adam Michael Stewart; Allan V Kalueff
Journal:  Behav Brain Res       Date:  2012-09-04       Impact factor: 3.332

Review 5.  Capturing the angel in "angel dust": twenty years of translational neuroscience studies of NMDA receptor antagonists in animals and humans.

Authors:  Bita Moghaddam; John H Krystal
Journal:  Schizophr Bull       Date:  2012-08-16       Impact factor: 9.306

6.  Behavioral effects of MDMA ('ecstasy') on adult zebrafish.

Authors:  Adam Stewart; Russell Riehl; Keith Wong; Jeremy Green; Jessica Cosgrove; Karoly Vollmer; Evan Kyzar; Peter Hart; Alexander Allain; Jonathan Cachat; Siddharth Gaikwad; Molly Hook; Kate Rhymes; Alan Newman; Eli Utterback; Katie Chang; Allan V Kalueff
Journal:  Behav Pharmacol       Date:  2011-06       Impact factor: 2.293

Review 7.  Animal models of serotonergic psychedelics.

Authors:  James B Hanks; Javier González-Maeso
Journal:  ACS Chem Neurosci       Date:  2012-09-24       Impact factor: 4.418

Review 8.  Serotonin research: contributions to understanding psychoses.

Authors:  Mark A Geyer; Franz X Vollenweider
Journal:  Trends Pharmacol Sci       Date:  2008-09       Impact factor: 14.819

9.  Effects of Schedule I drug laws on neuroscience research and treatment innovation.

Authors:  David J Nutt; Leslie A King; David E Nichols
Journal:  Nat Rev Neurosci       Date:  2013-06-12       Impact factor: 34.870

  9 in total
  3 in total

Review 1.  Zebrafish as an emerging model for studying complex brain disorders.

Authors:  Allan V Kalueff; Adam Michael Stewart; Robert Gerlai
Journal:  Trends Pharmacol Sci       Date:  2014-01-09       Impact factor: 14.819

2.  New victims of current drug laws.

Authors:  David J Nutt; Leslie A King; David E Nichols
Journal:  Nat Rev Neurosci       Date:  2013-10-23       Impact factor: 34.870

3.  Developing highER-throughput zebrafish screens for in-vivo CNS drug discovery.

Authors:  Adam Michael Stewart; Robert Gerlai; Allan V Kalueff
Journal:  Front Behav Neurosci       Date:  2015-02-12       Impact factor: 3.558

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.